ICREA professor Raúl Méndez publishes a study in Nature describing how the CPBE1 protein "takes the brakes off" the production of proteins associated with the cell switch from being healthy to tumorous. The study highlights CPEB proteins as promising targets, thus opening up a new and unexplored therapeutic window. The lab has developed a system for screening compounds that impede the action of CPEB proteins in tumors.
↧